Stephens Reiterates Overweight Rating for 908 Devices (NASDAQ:MASS)

908 Devices (NASDAQ:MASS - Get Free Report)'s stock had its "overweight" rating reiterated by research analysts at Stephens in a report issued on Wednesday,Benzinga reports. They currently have a $6.00 price objective on the stock. Stephens' price target points to a potential upside of 106.90% from the company's previous close.

A number of other brokerages have also commented on MASS. Leerink Partners restated a "market perform" rating and set a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Leerink Partnrs lowered shares of 908 Devices from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, November 13th. Finally, Stifel Nicolaus dropped their price target on shares of 908 Devices from $17.00 to $6.00 and set a "buy" rating on the stock in a research report on Wednesday, November 13th.

908 Devices Trading Down 0.3 %

MASS stock traded down $0.01 during trading on Wednesday, reaching $2.90. 1,944,993 shares of the stock were exchanged, compared to its average volume of 1,729,689. The firm's 50 day moving average is $2.39 and its 200 day moving average is $3.53. The firm has a market cap of $100.98 million, a P/E ratio of -1.64 and a beta of 0.96. 908 Devices has a twelve month low of $1.81 and a twelve month high of $8.50.

Hedge Funds Weigh In On 908 Devices

Large investors have recently made changes to their positions in the stock. SG Americas Securities LLC bought a new position in shares of 908 Devices in the third quarter worth approximately $36,000. B. Riley Wealth Advisors Inc. bought a new position in 908 Devices during the 3rd quarter valued at approximately $45,000. Drive Wealth Management LLC bought a new stake in 908 Devices in the third quarter valued at $50,000. Townsquare Capital LLC purchased a new position in shares of 908 Devices during the third quarter valued at about $50,000. Finally, 49 Wealth Management LLC grew its holdings in shares of 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company's stock worth $108,000 after acquiring an additional 4,343 shares during the period. 88.06% of the stock is owned by institutional investors.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.